checkAd
    Startseite > Aktien > Personalis > Nachrichten
    Personalis Aktie
    1,5700
     
    USD
    -4,85 %
    -0,0800 USD
    Letzter Kurs 11.05.24 Nasdaq
    1,5700
     
    USD
    700 STK
    Geldkurs 10.05.24
    1,5800
     
    USD
    900 STK
    Briefkurs 10.05.24
    ISIN: US71535D1063 · WKN: A2PLTK · SYM: PSNL · USA

    Neueste Nachrichten

    Personalis Reports First Quarter 2024 Financial Results
    08.05.24 · Business Wire (engl.) · Personalis
    Personalis to Announce First Quarter 2024 Financial Results
    24.04.24 · Business Wire (engl.) · Personalis
    Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
    28.03.24 · Business Wire (engl.) · Personalis
    Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    28.03.24 · Business Wire (engl.) · Personalis
    Personalis Announces Publication Validating NeXT Personal Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
    26.03.24 · Business Wire (engl.) · Personalis
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    19.03.24 · Business Wire (engl.) · Personalis
    Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
    28.02.24 · Business Wire (engl.) · Personalis
    Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
    14.02.24 · Business Wire (engl.) · Personalis
    Personalis to Participate at Upcoming Investor Conferences
    31.01.24 · Business Wire (engl.) · Personalis
    Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
    30.01.24 · Business Wire (engl.) · Personalis
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    17.01.24 · Business Wire (engl.) · Personalis
    Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
    16.01.24 · Business Wire (engl.) · Personalis